The Claim
Creatine monohydrate supplementation at 20g/day for eight weeks is feasible in adults with probable Alzheimer’s disease, with 95% of participants achieving at least 80% adherence as reported by self-report and caregiver-assisted tracking.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with probable Alzheimer’s disease, taking 20 grams of creatine monohydrate daily for eight weeks was feasible, and 95% of participants followed the regimen at least 80% of the time based on self-reports and caregiver tracking.
See the scientific wording
Creatine monohydrate supplementation at 20g/day for eight weeks is feasible in adults with probable Alzheimer’s disease, with 95% of participants achieving ≥80% adherence as reported by self-report and caregiver-assisted tracking.
When a person takes creatine pills, the creatine enters the bloodstream from the gut, travels to the brain, and crosses into brain cells using a specific transport system. Once inside, it builds up and stays there, increasing the brain's energy reserves.
What the research says
1 studyIn a study with older adults who have Alzheimer’s, almost everyone (95%) took their daily creatine pill for eight weeks with help from family members, proving it’s doable.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.